Compliance Rate
Compliance Rate
51.23%
Compliant submissions
187
Incompliant submissions
178
Total trials
365
My Organizations' Clinical Trials
Showing 1200 of 2400 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/07/07
End: 03/08/11
Due: 03/08/12
Phase: N/A
Priority: Normal
Start: 04/20/21
End: 11/20/22
Due: 11/20/23
Phase: N/A
Priority: Normal
Start: 12/27/17
End: 09/25/19
Due: 09/25/20
Phase: N/A
Priority: Normal
Start: 08/06/13
End: 05/04/17
Due: 05/04/18
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 07/31/06
Due: 07/31/07
Phase: N/A
Priority: Normal
Start: -
End: 03/31/05
Due: 03/31/06
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/01
End: 05/31/04
Due: 05/31/05
Phase: N/A
Priority: Normal
Start: 05/25/23
End: 02/11/24
Due: 02/11/25
Phase: N/A
Priority: Normal
Start: -
End: 06/30/92
Due: 06/30/93
Phase: N/A
Priority: Normal
Start: 10/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/10/19
End: 09/18/20
Due: 09/18/21
Phase: N/A
Priority: Normal
Start: 12/31/05
End: 09/30/09
Due: 09/30/10
Phase: N/A
Priority: Normal
Start: -
End: 05/31/95
Due: 05/31/96
Phase: N/A
Priority: Normal
Start: 02/22/17
End: 10/03/19
Due: 10/03/20
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/04/19
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 05/23/77
End: 05/31/17
Due: 05/31/18
Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization
Phase: N/A
Priority: Normal
Start: 06/30/80
End: 06/30/00
Due: 06/30/01
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: -
End: 07/31/02
Due: 07/31/03
Phase: N/A
Priority: Normal
Start: 08/01/16
End: 05/31/17
Due: 05/31/18